Sensible Biotechnologies

Unlocking the next generation of mRNA medicines

Sensible Biotechnologies is active in the healthcare space based in Oxford, England, United Kingdom.

Profile

The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.

The company sits in the healthcare segment, where it competes on its core product or service.

Its base of operations is Oxford, England, United Kingdom.

Its current recorded stage is Summer 2021.

Its team size is recorded as 24 employees.

Website: sensible.bio